Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldara Cream 5% in Extensive Alopecia Areata
NCT00176943Phase 4Completed
- Start
- Oct 2000
- Primary completion
- Aug 2002
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of imiquimod in alopecia areata. Primary endpoint: Phenotypic characteristics of T lymphocytes infiltrating scalp dermis and epidermis at 6 months. Started Oct 2000; status: completed.
02
Drugs
imiquimod
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT00176943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00176943.